Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat

NCT00925132 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Stopped Change in the number of approved drugs for metastatic melanoma

Conditions

Metastatic Melanoma

Interventions

DRUG: Temozolomide, Decitabine, Panobinostat

Sponsor

University of Iowa

Collaborators

[object Object]
[object Object]